BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 36048859)

  • 1. Combinatorial treatment with exercise and AICAR potentiates the rescue of myotonic dystrophy type 1 mouse muscles in a sex-specific manner.
    Misquitta NS; Ravel-Chapuis A; Jasmin BJ
    Hum Mol Genet; 2023 Jan; 32(4):551-566. PubMed ID: 36048859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological and exercise-induced activation of AMPK as emerging therapies for myotonic dystrophy type 1 patients.
    Ravel-Chapuis A; Duchesne E; Jasmin BJ
    J Physiol; 2022 Jul; 600(14):3249-3264. PubMed ID: 35695045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting deregulated AMPK/mTORC1 pathways improves muscle function in myotonic dystrophy type I.
    Brockhoff M; Rion N; Chojnowska K; Wiktorowicz T; Eickhorst C; Erne B; Frank S; Angelini C; Furling D; Rüegg MA; Sinnreich M; Castets P
    J Clin Invest; 2017 Feb; 127(2):549-563. PubMed ID: 28067669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic exercise mitigates disease mechanisms and improves muscle function in myotonic dystrophy type 1 mice.
    Manta A; Stouth DW; Xhuti D; Chi L; Rebalka IA; Kalmar JM; Hawke TJ; Ljubicic V
    J Physiol; 2019 Mar; 597(5):1361-1381. PubMed ID: 30628727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological and physiological activation of AMPK improves the spliceopathy in DM1 mouse muscles.
    Ravel-Chapuis A; Al-Rewashdy A; Bélanger G; Jasmin BJ
    Hum Mol Genet; 2018 Oct; 27(19):3361-3376. PubMed ID: 29982462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of exercise intensity and AICAR on isoform-specific expressions of murine skeletal muscle PGC-1α mRNA: a role of β₂-adrenergic receptor activation.
    Tadaishi M; Miura S; Kai Y; Kawasaki E; Koshinaka K; Kawanaka K; Nagata J; Oishi Y; Ezaki O
    Am J Physiol Endocrinol Metab; 2011 Feb; 300(2):E341-9. PubMed ID: 21098736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide-conjugated oligonucleotides evoke long-lasting myotonic dystrophy correction in patient-derived cells and mice.
    Klein AF; Varela MA; Arandel L; Holland A; Naouar N; Arzumanov A; Seoane D; Revillod L; Bassez G; Ferry A; Jauvin D; Gourdon G; Puymirat J; Gait MJ; Furling D; Wood MJ
    J Clin Invest; 2019 Nov; 129(11):4739-4744. PubMed ID: 31479430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prior treatment with the AMPK activator AICAR induces subsequently enhanced glucose uptake in isolated skeletal muscles from 24-month-old rats.
    Oki K; Arias EB; Kanzaki M; Cartee GD
    Appl Physiol Nutr Metab; 2018 Aug; 43(8):795-805. PubMed ID: 29518344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial dysfunction in skeletal muscle of fukutin-deficient mice is resistant to exercise- and 5-aminoimidazole-4-carboxamide ribonucleotide-induced rescue.
    Southern WM; Nichenko AS; Qualls AE; Portman K; Gidon A; Beedle AM; Call JA
    Exp Physiol; 2020 Oct; 105(10):1767-1777. PubMed ID: 32833332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcitriol increases MBNL1 expression and alleviates myotonic dystrophy phenotypes in HSA
    Huang K; Wang DD; Hu WB; Zeng WQ; Xu X; Li QX; Bi FF; Yang H; Qiu J
    J Transl Med; 2022 Dec; 20(1):588. PubMed ID: 36510245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age of onset of RNA toxicity influences phenotypic severity: evidence from an inducible mouse model of myotonic dystrophy (DM1).
    Gladman JT; Mandal M; Srinivasan V; Mahadevan MS
    PLoS One; 2013; 8(9):e72907. PubMed ID: 24039817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of alpha-AMPK knockout on exercise-induced gene activation in mouse skeletal muscle.
    Jørgensen SB; Wojtaszewski JF; Viollet B; Andreelli F; Birk JB; Hellsten Y; Schjerling P; Vaulont S; Neufer PD; Richter EA; Pilegaard H
    FASEB J; 2005 Jul; 19(9):1146-8. PubMed ID: 15878932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combinatorial therapies for rescuing myotonic dystrophy type 1 skeletal muscle defects.
    Ravel-Chapuis A; Jasmin BJ
    Trends Mol Med; 2022 Jun; 28(6):439-442. PubMed ID: 35537989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The hallmarks of myotonic dystrophy type 1 muscle dysfunction.
    Ozimski LL; Sabater-Arcis M; Bargiela A; Artero R
    Biol Rev Camb Philos Soc; 2021 Apr; 96(2):716-730. PubMed ID: 33269537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single dose of exercise stimulates skeletal muscle mitochondrial plasticity in myotonic dystrophy type 1.
    Mikhail AI; Manta A; Ng SY; Osborne AK; Mattina SR; Mackie MR; Ljubicic V
    Acta Physiol (Oxf); 2023 Apr; 237(4):e13943. PubMed ID: 36726043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of LKB1 and AMPK-related kinases in skeletal muscle: effects of contraction, phenformin, and AICAR.
    Sakamoto K; Göransson O; Hardie DG; Alessi DR
    Am J Physiol Endocrinol Metab; 2004 Aug; 287(2):E310-7. PubMed ID: 15068958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic AMPK activation evokes the slow, oxidative myogenic program and triggers beneficial adaptations in mdx mouse skeletal muscle.
    Ljubicic V; Miura P; Burt M; Boudreault L; Khogali S; Lunde JA; Renaud JM; Jasmin BJ
    Hum Mol Genet; 2011 Sep; 20(17):3478-93. PubMed ID: 21659335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of adenosine 5'-monophosphate-activated protein kinase in interleukin-6 release from isolated mouse skeletal muscle.
    Glund S; Treebak JT; Long YC; Barres R; Viollet B; Wojtaszewski JF; Zierath JR
    Endocrinology; 2009 Feb; 150(2):600-6. PubMed ID: 18818284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockout of the alpha2 but not alpha1 5'-AMP-activated protein kinase isoform abolishes 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranosidebut not contraction-induced glucose uptake in skeletal muscle.
    Jørgensen SB; Viollet B; Andreelli F; Frøsig C; Birk JB; Schjerling P; Vaulont S; Richter EA; Wojtaszewski JF
    J Biol Chem; 2004 Jan; 279(2):1070-9. PubMed ID: 14573616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of RNA toxicity in myotonic dystrophy via a decoy RNA-binding protein with high affinity for expanded CUG repeats.
    Arandel L; Matloka M; Klein AF; Rau F; Sureau A; Ney M; Cordier A; Kondili M; Polay-Espinoza M; Naouar N; Ferry A; Lemaitre M; Begard S; Colin M; Lamarre C; Tran H; Buée L; Marie J; Sergeant N; Furling D
    Nat Biomed Eng; 2022 Feb; 6(2):207-220. PubMed ID: 35145256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.